Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery

Summary Although venous thromboembolism (VTE) is the leading cause of maternal mortality in developed countries, the usefulness of preventive low-molecular-weight heparin (LMWH) after cesarean delivery remains a matter of controversy. It was the objective of this study to evaluate the usefulness of thromboprophylaxis with LMWH after cesarean delivery. A decision model was constructed to evaluate the risks and benefits associated with a seven-day LMWH prophylaxis, compared with none. All probabilities were obtained from literature according to the highest level of evidence. We performed our analysis on two different sets of outcomes (utilities and disutilities), to calculate the quality-adjusted life expectancy at three months. Finally, we calculated the outcomes for four hypothetical cases with different risk. Prophylaxis with LMWH yielded the highest quality-adjusted life expectancy, with a net gain of 1.5–2.8 quality-adjusted days. Sensitivity analyses showed the incidence of VTE after cesarean delivery and the haemorrhagic risk related to LMWH to be critical, at threshold values of 0.15–0.22% and 0.23–0.35%, respectively. In the hypothetical cases, LMWH was safe but only marginally more effective in women with no risk factors. In case of an emergency procedure, a body-mass index >25kg/m2, tobacco smoking, or any combination of these, reductions in VTE greatly outnumbered the increase in major haemorrhages, with a modest benefit on mortality. Our decision analysis suggests that the benefits of LMWH after cesarean delivery exceed the risks. This benefit is, however, very low in women with no risk factors.

[1]  S. Bates,et al.  Venous thromboembolism in pregnancy: diagnosis, management and prevention , 2009, Thrombosis and Haemostasis.

[2]  F. Rosendaal,et al.  Risk factors for post‐thrombotic syndrome in patients with a first deep venous thrombosis , 2008, Journal of thrombosis and haemostasis : JTH.

[3]  P. Prandoni,et al.  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. , 2008, Annals of internal medicine.

[4]  W. Chan,et al.  Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism , 2008, Thrombosis and Haemostasis.

[5]  J. Hirsh,et al.  Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[6]  P. Sandset,et al.  Ante‐ and postnatal risk factors of venous thrombosis: a hospital‐based case–control study , 2008, Journal of thrombosis and haemostasis : JTH.

[7]  T. Ikenoue,et al.  Pulmonary thromboembolism in obstetrics and gynecology increased by 6.5-fold over the past decade in Japan. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[8]  P. Brocklehurst,et al.  Cesarean Delivery and Peripartum Hysterectomy , 2008, Obstetrics and gynecology.

[9]  M. Spannagl,et al.  Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women , 2007, Thrombosis and Haemostasis.

[10]  H. Krum,et al.  Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.

[11]  M. Kominiarek,et al.  Low-molecular-weight heparin in pregnancy: peripartum bleeding complications , 2007, Journal of Perinatology.

[12]  S. Kilpatrick,et al.  Postpartum hemorrhage: a recurring pregnancy complication. , 2007, Seminars in perinatology.

[13]  H. Bounameaux,et al.  Prophylaxie des événements thromboemboliques veineux , 2007 .

[14]  F. Menacker,et al.  Cesarean delivery: background, trends, and epidemiology. , 2006, Seminars in perinatology.

[15]  P. Morange,et al.  Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin. , 2006, Blood.

[16]  B. Sibai,et al.  Blood Transfusion and Cesarean Delivery , 2006, Obstetrics and gynecology.

[17]  C. Ko,et al.  The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. , 2006, Archives of surgery.

[18]  Mark Stevenson,et al.  Measurement of the clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis. , 2006, Health technology assessment.

[19]  M. Rodger,et al.  Pelvic magnetic resonance venography reveals high rate of pelvic vein thrombosis after cesarean section. , 2006, American journal of obstetrics and gynecology.

[20]  K. Bailey,et al.  Trends in the Incidence of Venous Thromboembolism during Pregnancy or Postpartum: A 30-Year Population-Based Study , 2005, Annals of Internal Medicine.

[21]  P. Wells,et al.  Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. , 2005, Blood.

[22]  G. Macones,et al.  Thromboprophylaxis After Cesarean Delivery: A Decision Analysis , 2005, Obstetrics and gynecology.

[23]  E. Steegers,et al.  Postpartum Hemorrhage and Transfusion of Blood and Blood Components , 2005, Obstetrical & gynecological survey.

[24]  A. Many,et al.  The safety of low molecular weight heparin therapy during labor , 2005, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[25]  Kenneth J. Smith,et al.  Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism. , 2005, Chest.

[26]  I. Greer,et al.  Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. , 2005, Blood.

[27]  J. Morrison,et al.  Postpartum Hemorrhage After Cesarean Delivery: An Analysis of Risk Factors , 2005, Southern medical journal.

[28]  Julia E. Aledort,et al.  The Cost Effectiveness of Gonorrhea Screening in Urban Emergency Departments , 2005, Sexually transmitted diseases.

[29]  T. Kohlmann,et al.  Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis , 2005, Thrombosis and Haemostasis.

[30]  C. Metreweli,et al.  Duplex ultrasound screening for deep vein thrombosis in Chinese after cesarean section , 2005, Acta obstetricia et gynecologica Scandinavica.

[31]  D. Subtil,et al.  [Postpartum hemorrhage: frequency, consequences in terms of health status, and risk factors before delivery]. , 2004, Journal de gynecologie, obstetrique et biologie de la reproduction.

[32]  S. Gates,et al.  Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin. , 2004, American journal of obstetrics and gynecology.

[33]  James Douketis,et al.  Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism , 2003, Annals of Internal Medicine.

[34]  G. Lindmark,et al.  Maternal health outcomes in Europe. , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[35]  M. Hicks,et al.  Cost-effectiveness of the bird's nest filter for preventing pulmonary embolism among patients with malignant brain tumors and deep venous thrombosis of the lower extremities , 2003, Supportive Care in Cancer.

[36]  J. Kelton,et al.  Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. , 2003, Archives of internal medicine.

[37]  Jeani Chang,et al.  Pregnancy-Related Mortality Surveillance — United States , 1991 – 1999 , 2003 .

[38]  A. Borel‐Derlon,et al.  Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies , 2001, BJOG : an international journal of obstetrics and gynaecology.

[39]  J. Douketis.  Prognosis in pulmonary embolism , 2001, Current opinion in pulmonary medicine.

[40]  R. Burrows,et al.  A randomised double‐blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study , 2001, BJOG : an international journal of obstetrics and gynaecology.

[41]  S. Laporte,et al.  Meta‐analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery , 2001, The British journal of surgery.

[42]  R. Silver,et al.  Heparin-induced thrombocytopenia is rare in pregnancy. , 2001, American journal of obstetrics and gynecology.

[43]  C. Eby,et al.  Postpartum coronary artery dissection complicated by heparin-induced thrombocytopenia and thrombosis. , 2001, The Annals of thoracic surgery.

[44]  R. Farmer,et al.  Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database , 2001, BJOG : an international journal of obstetrics and gynaecology.

[45]  B. Kalro,et al.  Low incidence of asymptomatic deep venous thrombosis following caesarean section: a colour Doppler study. , 1999, Health bulletin.

[46]  K. Maršál,et al.  Thrombotic risk during pregnancy: a population study. , 1999, Obstetrics and gynecology.

[47]  B. Brenner,et al.  Safety of Low-Molecular-Weight Heparin in Pregnancy: A Systematic Review , 1999, Thrombosis and Haemostasis.

[48]  I. Greer.  Thrombosis in pregnancy: maternal and fetal issues , 1999, The Lancet.

[49]  R. Gherman,et al.  Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. , 1998, Primary care update for Ob/Gyns.

[50]  W M O'Fallon,et al.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. , 1998, Archives of internal medicine.

[51]  J. Douketis,et al.  Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. , 1998, JAMA.

[52]  C. Berg,et al.  Pregnancy-related mortality surveillance--United States, 1987-1990. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[53]  I. Greer,et al.  Venous Thromboembolic Disease in Obstetrics and Gynaecology: The Scottish Experience , 1996, Scottish medical journal.

[54]  J. O'Meara,et al.  A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. , 1994, The New England journal of medicine.

[55]  C. Combs,et al.  Factors Associated With Hemorrhage in Cesarean Deliveries , 1991, Obstetrics and gynecology.

[56]  D. Bergqvist,et al.  ACUTE DEEP VEIN THROMBOSIS (DVT) AFTER CESAREAN SECTION , 1979, Acta obstetricia et gynecologica Scandinavica.

[57]  M. Phipps,et al.  The incidence of deep vein thrombosis in women undergoing cesarean delivery. , 2009, Thrombosis research.

[58]  P. Sandset,et al.  Deep vein thrombosis after elective cesarean section. , 2004, Thrombosis research.

[59]  F. Haddad,et al.  Unanticipated variations between expected and delivered pneumatic compression therapy after elective hip surgery: a possible source of variation in reported patient outcomes. , 2001, The Journal of arthroplasty.

[60]  P. Prandoni,et al.  The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. , 1997, Haematologica.